Health Care: Drugs

ACADIA Pharmaceuticals Inc (ACAD: NASDAQ)

$40.22 n/a | n/a%
05/21/15 - 03:59 PM ET
Company Profile
Price and Volume
Recent Price 40.22
52 Week High 46.48
52 Week Low 19.21
Avg. Daily Vol. (Mil) 2.11
Beta (3 year) 2.68
Share Related Items
Mkt Cap (Mil) 4,033.96
Shares Out (Mil) 100.30
Float (Mil) 64.63
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 17.90
Current Ratio 18.00
LT Debt/ Equity 0.00
Total Debt / Equity 0.00
Valuation Ratios
Price Earnings n.a.
Price/Sales 42.46K
Price/Book 14.15
Price/Cash Flow -35.10
Per Share Data
Earnings -1.16
Sales 0.00
Book Value 2.84
Cash Flow -1.15
Business Summary
ACADIA Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the business of development and commercialization of small molecule drugs for the treatment of central nervous system disorders.
General Information
11085 Torreyana Road
Suite 100
San Diego, CA 92121
www.acadia-pharm.com
Industry : Drugs
Sector: Health Care
Employees: 119
CEO: Mr. Stephen R. Davis
Short Interest
Current Month (Mil) 14.32
Previous Month (Mil) 15.10
Short Interest Ratio (Days) 8.40
Management Effectiveness
Return on Equity n.a.
Return on Assets -38.10
Return on Investments -40.30
Profitability
Gross Margin n.a.
EBIT Margin n.a.
Profit Margin 0.00

Portfolios with ACAD

Latest ACAD Headlines from TheStreet

More Financial News for ACAD

Press Releases for ACAD

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter